CONSOLIDATED STATEMENT OF EQUITY - USD ($) $ in Thousands	Total	DeepHealth, Inc.	Radnet, Inc. Stockholders' Equity	Common Stock	Common Stock DeepHealth, Inc.	Additional Paid-In Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit	Noncontrolling Interests
Beginning balance (in shares) at Dec. 31, 2021				53,548,227
Beginning balance at Dec. 31, 2021	$ 346,157		$ 228,904	$ 5		$ 342,592	$ (20,421)	$ (93,272)	$ 117,253
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of stock upon exercise of options (in shares)				25,000
Issuance of common stock upon exercise of options	295		295	$ 1		294
Issuance of common stock under the equity compensation plan (in shares)				725,577	204,160
Issuance of common stock to settle DeepHealth contingent consideration (in shares)					781,577
Stock-based compensation expense	23,543		23,543			23,543
Forfeiture of restricted stock (in shares)				(26,710)
Forfeiture of restricted stock	(75)		(75)			(75)
Distributions paid to noncontrolling interests	(893)								(893)
Contributions from noncontrolling interests	19,139								19,139
Sale of economic interests in subsidiary	6,623		6,623			6,623
Issuance of common stock in connection with acquisitions (in shares)				2,465,294
Issuance of common stock in connection with acquisitions	63,311		63,311			63,311
Change in cumulative currency translation adjustment	(3,943)		(3,943)				(3,943)
Change in fair value of cash flow hedge from prior periods reclassified to earnings	3,687		3,687				3,687
Net income	33,608		10,650					10,650	22,958
Ending balance (in shares) at Dec. 31, 2022				57,723,125
Ending balance at Dec. 31, 2022	491,452		332,995	$ 6		436,288	(20,677)	(82,622)	158,457
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of stock upon exercise of options (in shares)				12,424
Issuance of common stock upon exercise of options	142		142			142
Issuance of common stock under the equity compensation plan (in shares)				1,128,453	37,909
Stock-based compensation expense	26,785		26,785			26,785
Issuance of common stock, net of issuance costs (in shares)				8,711,250
Issuance of common stock, net of issuance costs	245,832		245,832	$ 1		245,831
Forfeiture of restricted stock (in shares)				(35,542)
Distributions paid to noncontrolling interests	(5,972)								(5,972)
Contributions from noncontrolling interests	2,885								2,885
Sale of economic interests in subsidiary	2,236		2,236			2,236
Issuance of common stock in connection with acquisitions (in shares)				378,699
Issuance of common stock in connection with acquisitions			11,470			11,470
Change in cumulative currency translation adjustment	4,617		4,617				4,617
Change in fair value of cash flow hedge from prior periods reclassified to earnings	3,576		3,576				3,576
Other	(1)		(2)			(2)			1
Net income	$ 30,337		3,044					3,044	27,293
Ending balance (in shares) at Dec. 31, 2023	67,956,318			67,956,318
Ending balance at Dec. 31, 2023	$ 813,359		630,695	$ 7		722,750	(12,484)	(79,578)	182,664
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of stock upon exercise of options (in shares)	70,494	10,427		70,793
Issuance of common stock upon exercise of options	$ 667		667			667
Issuance of common stock under the equity compensation plan (in shares)				719,762	10,427
Stock-based compensation expense	29,986		29,986			29,986
Issuance of common stock, net of issuance costs (in shares)				5,232,500
Issuance of common stock, net of issuance costs	218,385		218,385	$ 0		218,385
Forfeiture of restricted stock (in shares)				(47,826)
Forfeiture of restricted stock	(153)		(153)			(153)
Distributions paid to noncontrolling interests	(4,522)								(4,522)
Sale of economic interests in subsidiary	28,822		11,905			11,905			16,917
Issuance of common stock in connection with acquisitions (in shares)				95,019
Issuance of common stock in connection with acquisitions			4,607			4,607
Change in cumulative currency translation adjustment	(5,929)		(5,929)				(5,929)
Change in fair value of cash flow hedge from prior periods reclassified to earnings	9,352		9,352				9,352
Net income	$ 38,836		2,793					2,793	36,043
Ending balance (in shares) at Dec. 31, 2024	67,956,318			74,036,993
Ending balance at Dec. 31, 2024	$ 1,133,410		$ 902,308	$ 7		$ 988,147	$ (9,061)	$ (76,785)	$ 231,102